Real-time enrollment status for this primary immunodeficiency disorders clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:08 PM UTC
| NCT Number | NCT03394053 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiency Disorders |
| Phase | Clinical Trial |
| Target Enrollment | 2,500 participants |
| Active Locations | 2 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | July 8, 2026 (5 days ago) |
As of July 13, 2026: Clinical trial NCT03394053 is currently recruiting participants. This clinical trial study for primary immunodeficiency disorders is actively seeking new participants at 2 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03394053 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03394053 was last updated 5 days ago (July 8, 2026). HelloStudys verifies this status automatically.